Novartis Gains FDA Approval for Amturnide™, a Triple-Combination Pill to Treat High Blood Pressure in Patients Uncontrolled on Two Medications

Novartis Gains FDA Approval for Amturnide™, a Triple-Combination Pill to Treat High Blood Pressure in Patients Uncontrolled on Two Medications

Dec 22, 2010
Source URL: https://qa1.novartis.us/us-en/news/media-releases/novartis-gains-fda-approval-amturnidetm-triple-combination-pill-treat-high-blood-pressure-patients-uncontrolled-two-medications-0

List of links present in page
  1. https://qa1.novartis.us/us-en/us-en/news/media-releases/novartis-gains-fda-approval-amturnidetm-triple-combination-pill-treat-high-blood-pressure-patients-uncontrolled-two-medications-0